Big Pharma Split Corp Preferred Stock (PRM.PR.A)
Market Closed
7 Aug, 20:00
TSX TSX Primary CA$
10. 20
0
0%
CA$
- Market Cap
- P/E Ratio
0.5% Div Yield
100 Volume
- Eps
CA$ 10.2
Previous Close Want to track PRM.PR.A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
PRM.PR.A closed Friday higher at CA$10.2, an increase of 0% from Thursday's close, completing a monthly increase of 0% or CA$0. Over the past 12 months, PRM.PR.A stock gained 0.0981%.
PRM.PR.A pays dividends to its shareholders, with the most recent payment made on May 07, 2026.
The stock of the company had never split.
The company's stock is traded on one exchange.
PRM.PR.A Chart
Big Pharma Split Corp Preferred Stock (PRM.PR.A) FAQ
What is the stock price today?
The current price is CA$10.20.
On which exchange is it traded?
Big Pharma Split Corp Preferred Stock is listed on TSX.
What is its stock symbol?
The ticker symbol is PRM.PR.A.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.5%.
What is its market cap?
As of today, no market cap data is available.
Has Big Pharma Split Corp Preferred Stock ever had a stock split?
No, there has never been a stock split.
Big Pharma Split Corp Preferred Stock Profile
| Capital Markets Industry | Financials Sector | - CEO | TSX Exchange | - ISIN |
| Canada Country | - Employees | 30 Apr 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Big Pharma Split Corp is a specialized investment vehicle, constituting a closed-ended equity mutual fund that was established and is actively managed by Harvest Portfolios Group Inc. Its focus lies within the public equity markets across the United States, with a specific emphasis on investments in the Pharmaceutical sector. Formally inaugurated on September 15, 2017, Big Pharma Split Corp operates from its base in Canada, aiming to offer investors targeted exposure to the pharmaceutical industry, which is renowned for its potential for steady growth and innovation.
Products and Services
Big Pharma Split Corp provides a distinct investment approach through its singular product offering:
- Pharmaceutical Sector Investment Fund: This fund is the cornerstone of Big Pharma Split Corp's portfolio, designed to offer investors direct exposure to the pharmaceutical sector. The focus is on leveraging the growth and stability of established pharmaceutical companies in the public equity markets of the United States. By prioritizing investments in this sector, the fund aims to capitalize on the dynamic advancements and the resilient market demand characteristic of the pharmaceutical industry. The investment strategy employed seeks to harness both dividend income and capital appreciation, providing a balanced approach for investors interested in the pharmaceutical space.
Contact Information
Address: 610 Chartwell Road
Phone: 416-649-4541
